Endoscopic management of ampullary tumors: European Society of
Gastrointestinal Endoscopy (ESGE) Guideline

J 2021

Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

VANBIERVLIET, G., M. STRIJKER, M. ARVANITAKIS, A. AELVOET, U. ARNELO et. al.

Základní údaje

Originální název

Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Autoři

VANBIERVLIET, G. (garant), M. STRIJKER, M. ARVANITAKIS, A. AELVOET, U. ARNELO, T. BEYNA, O. BUSCH, P. H. DEPREZ, Lumír KUNOVSKÝ (203 Česká republika, domácí), A. LARGHI, G. MANES, A. MOSS, B. NAPOLEON, M. NAYAR, E. PEREZ-CUADRADO-ROBLES, S. SEEWALD, M. BARTHET a J. E. VAN HOOFT

Vydání

Endoscopy, STUTTGART, GEORG THIEME VERLAG KG, 2021, 0013-726X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30212 Surgery

Stát vydavatele

Německo

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 9.776

Kód RIV

RIV/00216224:14110/21:00121429

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1055/a-1397-3198

UT WoS

000629334400001

Klíčová slova anglicky

ampullary tumors; endoscopic management

Štítky

14110213, 14110223, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 17. 5. 2022 09:00, Mgr. Tereza Miškechová

Anotace

V originále

Main Recommendations 1 ESGE recommends against diagnostic/therapeutic papillectomy when adenoma is not proven. Strong recommendation, low quality evidence. 2 ESGE recommends endoscopic ultrasound and abdominal magnetic resonance cholangiopancreatography (MRCP) for staging of ampullary tumors. Strong recommendation, low quality evidence. 3 ESGE recommends endoscopic papillectomy in patients with ampullary adenoma without intraductal extension, because of good results regarding outcome (technical and clinical success, morbidity, and recurrence). Strong recommendation, moderate quality evidence. 4 ESGE recommends en bloc resection of ampullary adenomas up to 20-30mm in diameter to achieve R0 resection, for optimizing the complete resection rate, providing optimal histopathology, and reduction of the recurrence rate after endoscopic papillectomy. Strong recommendation, low quality evidence. 5 ESGE suggests considering surgical treatment of ampullary adenomas when endoscopic resection is not feasible for technical reasons (e.g. diverticulum, size >4cm), and in the case of intraductal involvement (of >20mm). Surveillance thereafter is still mandatory. Weak recommendation, low quality evidence. 6 ESGE recommends direct snare resection without submucosal injection for endoscopic papillectomy. Strong recommendation, moderate quality evidence. 7 ESGE recommends prophylactic pancreatic duct stenting to reduce the risk of pancreatitis after endoscopic papillectomy. Strong recommendation, moderate quality evidence. 8 ESGE recommends long-term monitoring of patients after endoscopic papillectomy or surgical ampullectomy, based on duodenoscopy with biopsies of the scar and of any abnormal area, within the first 3 months, at 6 and 12 months, and thereafter yearly for at least 5 years. Strong recommendation, low quality evidence.

Citovat

VANBIERVLIET, G., M. STRIJKER, M. ARVANITAKIS, A. AELVOET, U. ARNELO, T. BEYNA, O. BUSCH, P. H. DEPREZ, Lumír KUNOVSKÝ, A. LARGHI, G. MANES, A. MOSS, B. NAPOLEON, M. NAYAR, E. PEREZ-CUADRADO-ROBLES, S. SEEWALD, M. BARTHET a J. E. VAN HOOFT. Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. STUTTGART: GEORG THIEME VERLAG KG, 2021, roč. 53, č. 04, s. 429-448. ISSN 0013-726X. Dostupné z: https://dx.doi.org/10.1055/a-1397-3198.

@article{1761817,
   author = {Vanbiervliet, G. and Strijker, M. and Arvanitakis, M. and Aelvoet, A. and Arnelo, U. and Beyna, T. and Busch, O. and Deprez, P. H. and Kunovský, Lumír and Larghi, A. and Manes, G. and Moss, A. and Napoleon, B. and Nayar, M. and PerezandCuadradoandRobles, E. and Seewald, S. and Barthet, M. and van Hooft, J. E.},
   article_location = {STUTTGART},
   article_number = {04},
   doi = {http://dx.doi.org/10.1055/a-1397-3198},
   keywords = {ampullary tumors; endoscopic management},
   language = {eng},
   issn = {0013-726X},
   journal = {Endoscopy},
   title = {Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline},
   url = {https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1397-3198},
   volume = {53},
   year = {2021}
}

TY  - JOUR
ID  - 1761817
AU  - Vanbiervliet, G. - Strijker, M. - Arvanitakis, M. - Aelvoet, A. - Arnelo, U. - Beyna, T. - Busch, O. - Deprez, P. H. - Kunovský, Lumír - Larghi, A. - Manes, G. - Moss, A. - Napoleon, B. - Nayar, M. - Perez-Cuadrado-Robles, E. - Seewald, S. - Barthet, M. - van Hooft, J. E.
PY  - 2021
TI  - Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
JF  - Endoscopy
VL  - 53
IS  - 04
SP  - 429-448
EP  - 429-448
PB  - GEORG THIEME VERLAG KG
SN  - 0013726X
KW  - ampullary tumors
KW  - endoscopic management
UR  - https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1397-3198
N2  - Main Recommendations 1 ESGE recommends against diagnostic/therapeutic papillectomy when adenoma is not proven. Strong recommendation, low quality evidence. 2 ESGE recommends endoscopic ultrasound and abdominal magnetic resonance cholangiopancreatography (MRCP) for staging of ampullary tumors. Strong recommendation, low quality evidence. 3 ESGE recommends endoscopic papillectomy in patients with ampullary adenoma without intraductal extension, because of good results regarding outcome (technical and clinical success, morbidity, and recurrence). Strong recommendation, moderate quality evidence. 4 ESGE recommends en bloc resection of ampullary adenomas up to 20-30mm in diameter to achieve R0 resection, for optimizing the complete resection rate, providing optimal histopathology, and reduction of the recurrence rate after endoscopic papillectomy. Strong recommendation, low quality evidence. 5 ESGE suggests considering surgical treatment of ampullary adenomas when endoscopic resection is not feasible for technical reasons (e.g. diverticulum, size >4cm), and in the case of intraductal involvement (of >20mm). Surveillance thereafter is still mandatory. Weak recommendation, low quality evidence. 6 ESGE recommends direct snare resection without submucosal injection for endoscopic papillectomy. Strong recommendation, moderate quality evidence. 7 ESGE recommends prophylactic pancreatic duct stenting to reduce the risk of pancreatitis after endoscopic papillectomy. Strong recommendation, moderate quality evidence. 8 ESGE recommends long-term monitoring of patients after endoscopic papillectomy or surgical ampullectomy, based on duodenoscopy with biopsies of the scar and of any abnormal area, within the first 3 months, at 6 and 12 months, and thereafter yearly for at least 5 years. Strong recommendation, low quality evidence.
ER  -

VANBIERVLIET, G., M. STRIJKER, M. ARVANITAKIS, A. AELVOET, U. ARNELO, T. BEYNA, O. BUSCH, P. H. DEPREZ, Lumír KUNOVSKÝ, A. LARGHI, G. MANES, A. MOSS, B. NAPOLEON, M. NAYAR, E. PEREZ-CUADRADO-ROBLES, S. SEEWALD, M. BARTHET a J. E. VAN HOOFT. Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. \textit{Endoscopy}. STUTTGART: GEORG THIEME VERLAG KG, 2021, roč.~53, č.~04, s.~429-448. ISSN~0013-726X. Dostupné z: https://dx.doi.org/10.1055/a-1397-3198.

Podrobný výpis o publikaci